Internal Medicine, Gastroenterology · Nashville, TN
NPI
1316034424
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
349 services
Medicare patients, 2024
212
Average age 69
Drug cost, 2024
$7.8M
1,205 prescriptions
Company payments, 2025
$264K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Schwartz was code 45380 (lower gi endoscopy - other), 95 times for 91 patients. In total David Schwartz billed 349 services in 31 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 45380 Lower GI Endoscopy - Other | Office | 95 | 91 | $108.96 | $10K |
| 99214 Office E&M - Established | Office | 46 | 33 | $72.63 | $3,341 |
| 45385 Colonoscopy - Lesion Removal | Office | 31 | 31 | $190.26 | $5,898 |
| 43239 Upper GI Endoscopy | Office | 27 | 26 | $74.46 | $2,010 |
| 99213 Office E&M - Established | Office | 23 | 18 | $47.73 | $1,098 |
| 45380 Lower GI Endoscopy - Other | Facility | 14 | 14 | $116.92 | $1,637 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 13 | 13 | $138.38 | $1,799 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $101.11 | $1,112 |
By year: 2022 $27K for 308 services; 2023 $35K for 371 services; 2024 $33K for 349 services.
Medicare prescription drug claims, 2024
In 2024, the drug David Schwartz prescribed most often to Medicare patients was Stelara (Ustekinumab), with 158 prescriptions and refills. In total David Schwartz wrote 1,205 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 158 | 189 | 20 | $4.3M |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 102 | 102 | 101 | $1,345 |
| Humira(Cf) Pen Adalimumab | 87 | 91 | Under 11 | $865K |
| Skyrizi On-Body Risankizumab-Rzaa | 68 | 118 | 12 | $1.4M |
| Rinvoq Upadacitinib | 58 | 58 | Under 11 | $471K |
| Pantoprazole Sodium Generic | 55 | 155 | 16 | $583 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 52 | 52 | 13 | $2,050 |
| Opium Tincture Generic | 36 | 36 | Under 11 | $14K |
| Dicyclomine Hcl Generic | 36 | 58 | Under 11 | $989 |
| Omeprazole Generic | 35 | 71 | 11 | $641 |
| Esomeprazole Magnesium Generic | 34 | 74 | Under 11 | $1,308 |
| Mesalamine Generic | 32 | 53 | 12 | $13K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 26 | 26 | 25 | $428 |
| Mesalamine Er Mesalamine | 25 | 55 | Under 11 | $10K |
| Entyvio Pen Vedolizumab | 25 | 25 | Under 11 | $241K |
Brand drugs: 538 claims; generic drugs: 631 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Schwartz $264K ($264K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $143K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.